NDC 45802-103
Alogliptin
Alogliptin
Alogliptin is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is Alogliptin Benzoate.
| Product ID | 45802-103_7255a53b-e2f0-466a-9ce7-d1df7babc9c1 |
| NDC | 45802-103 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Alogliptin |
| Generic Name | Alogliptin |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2016-04-08 |
| Marketing Category | NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC |
| Application Number | NDA022271 |
| Labeler Name | Padagis Israel Pharmaceuticals Ltd |
| Substance Name | ALOGLIPTIN BENZOATE |
| Active Ingredient Strength | 13 mg/1 |
| Pharm Classes | Dipeptidyl Peptidase 4 Inhibitor [EPC], Dipeptidyl Peptidase 4 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |